Microbot Medical Inc. Secures Key Patent in China for LIBERTY Endovascular Robotic System
Patent Acquisition: Microbot Medical Inc. has secured a significant patent in China for its LIBERTY Endovascular Robotic System, enhancing its global intellectual property strategy as it prepares for a U.S. launch in Q3 2025, pending FDA clearance.
Market Potential: The company is focusing on both U.S. and international markets, with millions of endovascular procedures performed annually, aiming to improve patient care through innovative robotic technology.
Get Free Real-Time Notifications for Any Stock
Analyst Views on MBOT
About MBOT
About the author

Reasons for Our Lack of Concern Regarding Microbot Medical's (NASDAQ:MBOT) Cash Burn Issue
Investor Interest in Unprofitable Companies: Microbot Medical's share price has surged 142% over the past year, attracting investor attention despite its lack of profitability and cash burn concerns.
Cash Burn and Runway Analysis: The company reported a cash burn of $11 million over the last year, with a cash runway of approximately 7.3 years, indicating a manageable financial situation for shareholders.
Growth Investment and Future Considerations: Although Microbot Medical's cash burn increased by 23%, suggesting a focus on future growth, this could shorten its cash runway if spending continues to rise.
Raising Capital and Market Position: With a market capitalization of $159 million, Microbot Medical's cash burn represents a low percentage of its market value, indicating potential ease in raising additional funds through share issuance or borrowing.

HC Wainwright & Co. Affirms Buy Rating for Microbot Medical, Keeps $12 Price Target Intact
Real-time Intelligence: Benzinga Pro offers the fastest news alerts to help traders stay informed and make timely decisions in the stock market.
Exclusive Content: Subscribers gain access to unique stories and insights generated by Benzinga reporters, enhancing their trading strategies.
Community of Traders: Over 10,000 serious traders are part of the Benzinga Pro community, sharing knowledge and resources.
Market Winning Tools: The platform is designed to provide traders with the tools they need to succeed in the markets every day.









